These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35699757)

  • 1. An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia.
    Nakagawa N; Hashii Y; Kayama H; Okumura R; Nakajima H; Minagawa H; Morimoto S; Fujiki F; Nakata J; Shirakawa T; Katayama T; Takeda K; Tsuboi A; Ozono K
    Cancer Immunol Immunother; 2023 Jan; 72(1):39-53. PubMed ID: 35699757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia.
    Minagawa H; Hashii Y; Nakajima H; Fujiki F; Morimoto S; Nakata J; Shirakawa T; Katayama T; Tsuboi A; Ozono K
    BMC Cancer; 2023 Feb; 23(1):167. PubMed ID: 36803483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein.
    Kitagawa K; Oda T; Saito H; Araki A; Gonoi R; Shigemura K; Hashii Y; Katayama T; Fujisawa M; Shirakawa T
    Cancer Immunol Immunother; 2017 Jun; 66(6):787-798. PubMed ID: 28299466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate Cancer.
    Kitagawa K; Gonoi R; Tatsumi M; Kadowaki M; Katayama T; Hashii Y; Fujisawa M; Shirakawa T
    Mol Cancer Ther; 2019 May; 18(5):980-990. PubMed ID: 30824610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine.
    Shirakawa T; Kitagawa K
    Hum Vaccin Immunother; 2018 Jan; 14(1):159-162. PubMed ID: 29048978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
    Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
    Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of DSP-7888 (adegramotide/nelatimotide) Emulsion, a peptide-based therapeutic cancer vaccine with the potential to turn up the heat on non-immunoreactive tumors.
    Suginobe N; Nakamura M; Takanashi Y; Ban H; Gotoh M
    Clin Transl Oncol; 2023 Feb; 25(2):396-407. PubMed ID: 36138335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.
    Osada T; Woo CY; McKinney M; Yang XY; Lei G; Labreche HG; Hartman ZC; Niedzwiecki D; Chao N; Amalfitano A; Morse MA; Lyerly HK; Clay TM
    Clin Cancer Res; 2009 Apr; 15(8):2789-96. PubMed ID: 19351755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
    Maslak PG; Dao T; Krug LM; Chanel S; Korontsvit T; Zakhaleva V; Zhang R; Wolchok JD; Yuan J; Pinilla-Ibarz J; Berman E; Weiss M; Jurcic J; Frattini MG; Scheinberg DA
    Blood; 2010 Jul; 116(2):171-9. PubMed ID: 20400682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141
    Pearson FE; Tullett KM; Leal-Rojas IM; Haigh OL; Masterman KA; Walpole C; Bridgeman JS; McLaren JE; Ladell K; Miners K; Llewellyn-Lacey S; Price DA; Tunger A; Schmitz M; Miles JJ; Lahoud MH; Radford KJ
    Clin Transl Immunology; 2020; 9(6):e1141. PubMed ID: 32547743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model.
    Ueki H; Kitagawa K; Kato M; Yanase S; Okamura Y; Bando Y; Hara T; Terakawa T; Furukawa J; Nakano Y; Fujisawa M; Shirakawa T
    Sci Rep; 2023 Jun; 13(1):9994. PubMed ID: 37340017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.
    Sundarasetty BS; Singh VK; Salguero G; Geffers R; Rickmann M; Macke L; Borchers S; Figueiredo C; Schambach A; Gullberg U; Provasi E; Bonini C; Ganser A; Woelfel T; Stripecke R
    Hum Gene Ther; 2013 Feb; 24(2):220-37. PubMed ID: 23311414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.
    Ferulli F; Tanzi M; Turin I; Montini E; Rosti V; Acquafredda G; Lisini D; Compagno F; Boghen S; Licari A; Marseglia G; Zecca M; Montagna D
    Cytotherapy; 2019 Sep; 21(9):958-972. PubMed ID: 31279696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA‑A2‑restricted WT1‑reactive CD8+ T cells.
    Kan S; Bito T; Shimabuku M; Taguchi J; Ohkusa T; Shimodaira S; Sugiyama H; Koido S
    Int J Oncol; 2020 Oct; 57(4):1047-1056. PubMed ID: 32945369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.
    Anguille S; Van de Velde AL; Smits EL; Van Tendeloo VF; Juliusson G; Cools N; Nijs G; Stein B; Lion E; Van Driessche A; Vandenbosch I; Verlinden A; Gadisseur AP; Schroyens WA; Muylle L; Vermeulen K; Maes MB; Deiteren K; Malfait R; Gostick E; Lammens M; Couttenye MM; Jorens P; Goossens H; Price DA; Ladell K; Oka Y; Fujiki F; Oji Y; Sugiyama H; Berneman ZN
    Blood; 2017 Oct; 130(15):1713-1721. PubMed ID: 28830889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.
    van Amerongen RA; Hagedoorn RS; Remst DFG; Assendelft DC; van der Steen DM; Wouters AK; van de Meent M; Kester MGD; de Ru AH; Griffioen M; van Veelen PA; Falkenburg JHF; Heemskerk MHM
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia.
    Sohn HJ; Lee JY; Lee HJ; Sohn DH; Cho HI; Kim HJ; Kim TG
    Oncotarget; 2017 Jul; 8(27):44059-44072. PubMed ID: 28477011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Grade Production of Wilms' Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation.
    Plantinga M; Lo Presti V; de Haar CG; Dünnebach E; Madrigal A; Lindemans CA; Boelens JJ; Nierkens S
    Front Immunol; 2020; 11():559152. PubMed ID: 33101274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.